Circulating sclerostin associated with vertebral bone marrow fat in older men but not women - Wikidata - wikimedia - TriplyDB

Circulating sclerostin associated with vertebral bone marrow fat in older men but not women

Circulating sclerostin associated with vertebral bone marrow fat in older men but not women

http://www.wikidata.org/entity/Q34628276

about

Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions The Bone Marrow-Derived Stromal Cells: Commitment and Regulation of Adipogenesis Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots.Marrow fat and bone: review of clinical findings.Reliable quantification of marrow fat content and unsaturation level using in vivo MR spectroscopy.The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis.Hormonal and systemic regulation of sclerostin.Pathophysiology of Bone Fragility in Patients with Diabetes.Bone Cell Bioenergetics and Skeletal Energy Homeostasis.Connecting Bone and Fat: The Potential Role for Sclerostin.Bone cells and bone turnover in diabetes mellitus.Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells.Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.The emerging role of bone marrow adipose tissue in bone health and dysfunction.Marrow Adiposity and Hematopoiesis in Aging and Obesity: Exercise as an Intervention.Marrow Adipose Tissue: Its Origin, Function, and Regulation in Bone Remodeling and Regeneration.

P2860

Q26750574-D99BF126-0411-43AF-9EF3-28B03294F95C Q28078585-86BF2C04-FD72-4773-A921-C5117983E09B Q33925973-5682FC2F-2602-4FC9-8110-4F25434A0F5A Q35229131-BFE8A1BE-105B-4A2E-B792-A978D35B3358 Q38676264-4AB1DDEF-B052-4F2D-8D37-D447B242397B Q38810794-857952DE-BCD1-436D-A5F0-36E91FFDFF5B Q39037907-7E3FC743-B8C4-41B3-8C6E-8F698E32B6A7 Q39127683-0FA6BE62-C853-4C86-8EC0-21391B732B50 Q39137277-72EA8A97-58F0-496F-B124-86D1112CBBB2 Q39350147-6354FCF6-6CB6-47C1-A148-6777703258F5 Q41294180-643D79C9-746B-4967-AF5D-AA7397DBBD80 Q42818418-6ADD8E82-B871-4F21-909D-CB02920C4376 Q47327411-BFDAF558-C900-40BF-AB9C-FB3740D7EA4C Q50172954-7858CD2A-FCDB-498A-BE66-946AC4ABA845 Q51767578-045A590A-070A-42C6-B670-29519BE3D0FD Q55405123-81E66CB6-A26D-46CE-A86D-71E38D1FCBE5

P2860

Circulating sclerostin associated with vertebral bone marrow fat in older men but not women

http://www.wikidata.org/entity/Q34628276

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating sclerostin associa ...... fat in older men but not women

@ast

Circulating sclerostin associa ...... fat in older men but not women

@en

Circulating sclerostin associa ...... fat in older men but not women

@nl

type

label

Circulating sclerostin associa ...... fat in older men but not women

@ast

Circulating sclerostin associa ...... fat in older men but not women

@en

Circulating sclerostin associa ...... fat in older men but not women

@nl

prefLabel

Circulating sclerostin associa ...... fat in older men but not women

@ast

Circulating sclerostin associa ...... fat in older men but not women

@en

Circulating sclerostin associa ...... fat in older men but not women

@nl

P1433

Q34628276-D99D347C-2FB3-4796-845A-5ED0C67653F3

P1476

Q34628276-0D51846F-0575-4A0C-96CC-EAAF5990FA33

P2093

Q34628276-0411FC97-106F-414F-822F-D9BC191A9E11

Q34628276-1279ADD8-539A-4869-8094-CD133CEBE6D6

Q34628276-133C399E-C3E5-431C-9C9F-2444A04ABD95

Q34628276-18A40487-887D-4300-9360-D6E9EA1C4F90

Q34628276-437EA6C0-824F-4D55-A6C5-CFA327E61541

Q34628276-63E230D7-5AC2-41A9-9ABE-052D3DBDCEC1

Q34628276-68EE1DBB-0A1E-4621-9AD0-AD2AF8BDD8A7

Q34628276-96197E9E-E0A9-4E66-9C6A-F58B9E2EB1D1

Q34628276-99CA956C-8BFA-463F-900E-3621DD5C5A9E

Q34628276-B3682D64-2CE0-446F-9CC8-9A58243FE016

P2860

Q34628276-00B15DE0-125D-43AD-8020-DB6DE587388C

Q34628276-1A922D62-AED9-4F34-B29A-B02AABB0E0C4

Q34628276-1AAD7A9D-C9AB-4E0A-B881-D66044D631A6

Q34628276-1BB8E860-00DB-4C8E-B842-51BBA4C788A8

Q34628276-1E21B1F7-F0D8-43EE-BDED-DEBA48712A85

Q34628276-232F9A55-C310-4593-9200-5736147F862B

Q34628276-333CA1CD-47DC-4779-9ED7-29E667AC64B3

Q34628276-4C15CC0F-3C08-4586-8493-5833061D4567

Q34628276-51D9D521-C5AC-4204-8E76-5B2FDDDF1BCD

Q34628276-5411A479-1256-47B5-B38B-596FE112ACC6

P304

Q34628276-0B0E6F4D-21E7-424E-A9CC-C5F3F9566134

P31

Q34628276-C95F4B02-4B1D-4FD0-9C85-E9853EE7BB66

P356

Q34628276-2750A09C-450B-4404-8C37-D01C37246D6B

P407

Q34628276-65AE1A9F-BE2A-410F-B2FA-9909045205ED

P433

Q34628276-77A7460A-A5F3-49CA-A521-20AB81F64D20

P478

Q34628276-E3366A58-9BE7-48DC-9EB1-D0E56D092C12

P50

Q34628276-02303734-C258-4A22-8C5E-BD318A9AF918

Q34628276-3CB98C05-B0D6-48F3-8CD3-D33AA1C1FA0A

Q34628276-701ED174-6672-4402-B5DC-E7126F77BD05

Q34628276-717C7702-7195-4C75-8363-702255C94350

Q34628276-7FCA6579-11CA-4FE8-B00A-471D308C5FDA

Q34628276-BFB8DEFC-D9BC-48AD-82EA-CE42E451FFED

P577

Q34628276-24EC8C1A-F35E-4354-8CA7-467839437130

P5875

Q34628276-C018C8E7-C066-4C8A-88CA-87647CBC0409

P698

Q34628276-95979D0C-F21B-4D34-A723-2F816077D9CF

P932

Q34628276-F635EA33-13C2-4BAC-8831-E79B2A9EA087

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Circulating sclerostin associa ...... fat in older men but not women

@en

P2093

Alda M Hauksdottir

http://www.w3.org/2001/XMLSchema#string

Ann V Schwartz

http://www.w3.org/2001/XMLSchema#string

Clifford J Rosen

http://www.w3.org/2001/XMLSchema#string

Diana Oskarsdottir

http://www.w3.org/2001/XMLSchema#string

Gunnar Sigurdsson

http://www.w3.org/2001/XMLSchema#string

Kristin Siggeirsdottir

http://www.w3.org/2001/XMLSchema#string

Lisa Palermo

http://www.w3.org/2001/XMLSchema#string

Sigurdur Sigurdsson

http://www.w3.org/2001/XMLSchema#string

Thomas F Lang

http://www.w3.org/2001/XMLSchema#string

Trisha F Hue

http://www.w3.org/2001/XMLSchema#string

P2860

Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells

WNT signaling in bone homeostasis and disease: from human mutations to treatments

Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.

Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies.

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms.

Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women.

Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays.

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

P304

E2584-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2013-4493

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Vilmundur Gudnason

Gudny Eiriksdottir

Eric Vittinghoff

Yu-Heng Vivian Ma

Tamara B Harris

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264939148

http://www.w3.org/2001/XMLSchema#string

P698

25144629

http://www.w3.org/2001/XMLSchema#string

P932

4255105

http://www.w3.org/2001/XMLSchema#string